The What, Why and How of Fetal Alcohol Spectrum Disorders Prevention
During the webinar Dr. Garry will provide an overview of alcohol use in pregnancy with some description of basic pathophysiology. What is Fetal Alcohol Spectrum Disorders and what measures can be taken to prevent or reduce alcohol use in pregnancy. Dr. Garry will be joined by a mother who will share her personal experience with FASD.
By participating in this course, the learner will be able to:
- Describe at least two clinical signs and symptoms of Fetal Alcohol Spectrum Disorders (FASD) in a newborn
- Describe the current incidence of FASD in the US
- State two new facts you have learned about alcohol use among pregnant women
- List two modifications to prenatal and antenatal screening for alcohol use during pregnancy as a strategy to improve maternal and/or neonatal outcomes
This session has been approved for 1.0 nursing CEs by the California Board of Registered Nurses, Provider Number 15417.
David J Garry, DO, FACOG
Division Director of Maternal Fetal Medicine
Stony Brook Medicine
David Garry specializes in high-risk pregnancies and is the division director of maternal fetal medicine at Stony Brook Medicine. He is a Professor in the Renaissance School of Medicine and supervises the Maternal Opioid Management Service for pregnant women requiring addiction medicine services. He is an American College of Obstetricians and Gynecologists FASD Champion for NY and has been involved in reducing alcohol exposed pregnancies since 2008.